Inventor · disambiguated record
Gary Shapiro
Also filed as: SHAPIRO GARY · SHAPIRO GARY LEE
6 granted patents·10 pending applications·150 citations·filing 1997–2025
82Inventor score
Files withTAKEDA PHARMACEUTICALS CO5SANOFI SA4MEMORIAL SLOAN KETTERING CANCER CENTER3AFFINI T THERAPEUTICS INC2BOSTON SCIENT SCIMED INC1
Top patents by PatentIndex Score
16 records- 0193US11242384B2Anti-TGF-beta antibodies and their useSANOFI SA·Filed 2020·Granted Feb 8, 2022·4 cites·14 claims
- 0286US10766955B2Anti-TGF-β antibodies and their useSANOFI SA·Filed 2018·Granted Sep 8, 2020·4 cites·33 claims
- 0381US2025026821A1Anti-tgf-beta antibodies and their useSANOFI SA·Filed 2024·Application pending·0 cites
- 0480US6246782B1System for automated detection of cancerous masses in mammogramsLOCKHEED CORP·Filed 1997·Granted Jun 12, 2001·100 cites·47 claims
- 0575US12049496B2Anti-TGF-beta antibodies and their useSANOFI SA·Filed 2021·Granted Jul 30, 2024·0 cites·10 claims
- 0666US7329269B2Intravascular filtering devices and methodsBOSTON SCIENT SCIMED INC·Filed 2003·Granted Feb 12, 2008·42 cites·21 claims
- 0762US12331129B2Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jun 17, 2025·0 cites·66 claims
- 0861US2025152717A1Binding proteins and engineered cells specific for neoantigens and uses thereofAFFINI T THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0960US2025250356A1Chimeric receptors targeting adgre2 and/or clec12a and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 1057US2023346938A1Chimeric antigen receptors targeting cd19 and use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1157US2024350627A1Engineered immune cell that specifically targets mesothelin and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1255US2024226295A9Cell therapy compositions and methods for modulating tgf-b signalingTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1354US2024033359A1Compositions of guanylyl cyclase c (gcc) antigen binding agents and methods of use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1452US2024050473A1Compositions of guanylyl cyclase c (gcc) antigen binding agents and methods of use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1552US2024374721A1Car-expressing immune cells that specifically target mesothelin and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1643US2025281614A1Chimeric receptors comprising interleukin 7 receptor (il7r) domainsAFFINI T THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary Shapiro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →